While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

The birds amassed fans, as legions of devotees follow along on webcams each spring as falcons progress from hatching to ...

Aggressive breast cancer can become unresponsive to monoclonal antibody treatment, but targeting tumor-resident bacteria may extend its effectiveness.